What is the appropriate evaluation and management for loss of post‑ganglionic cholinergic sweating (anhidrosis)?

Evaluation and Management of Loss of Postganglionic Cholinergic Sweat Response (Anhidrosis)

For suspected postganglionic cholinergic anhidrosis, perform QSART (Quantitative Sudomotor Axon Reflex Test) as the primary diagnostic test, as it specifically evaluates postganglionic sudomotor function with 75-90% sensitivity and can distinguish postganglionic from preganglionic lesions 1, 2.

Diagnostic Approach

Initial Testing Strategy

QSART is the gold standard for postganglionic sudomotor assessment because it:

• Directly measures postganglionic sympathetic sudomotor axon function through acetylcholine iontophoresis
• Detects distal small fiber polyneuropathy with >75% sensitivity
• Provides quantitative data (area under curve, maximal sweat production, sweat onset latency)
• Cannot be confounded by preganglionic or central lesions 1, 2

Alternative and Complementary Tests

If QSART is unavailable, consider this testing hierarchy:

Second-line options:

• QDIRT (Quantitative Direct and Indirect Reflex Test): Validated against QSART, measures postganglionic function using indicator dye. Caveat: Highly sensitive to temperature, humidity, hydration status, and caffeine intake—ensure standardized conditions 1
• Indicator plaster: Simple, rapid screening method with 85-95% sensitivity for peripheral neuropathy. Color change from blue to pink after 10 minutes of foot perspiration exposure 1

Avoid as primary tests:

• TST (Thermoregulatory Sweat Test): Cannot differentiate preganglionic from postganglionic lesions, time-consuming, requires specialized facilities 1
• SSR (Sympathetic Skin Response): Poor specificity (31-76% sensitivity), responses may be absent in >50-year-olds, no clear definition of abnormal 1

Combining Tests for Localization

When lesion localization is uncertain, combine QSART with TST to achieve 98% sensitivity and definitively localize the lesion 1. This combination distinguishes:

• Postganglionic lesions (abnormal QSART, normal central pathways on TST)
• Preganglionic/central lesions (abnormal TST, may have normal QSART)

Management Strategy

For Acquired Idiopathic Generalized Anhidrosis (AIGA)

If no underlying neurological, dermatological, or exogenous cause is identified, treat with systemic corticosteroids as first-line therapy 3, 4, 5:

1. Initiate steroid pulse therapy early—rapid treatment correlates with better outcomes 5
2. Expect multiple courses may be needed, particularly if anhidrotic area is large 6
3. Monitor for recurrence, which is common even after initial response 3

For Secondary Causes

The management algorithm depends on identifying the underlying etiology:

Neurological causes:

• If upper motor neuron pattern (spasticity, hyperreflexia): MRI brain/spinal cord
• If lower motor neuron pattern (flaccidity, hyporeflexia): Nerve conduction studies
• If autonomic dysfunction: Comprehensive autonomic testing 7

Dermatological causes:

• Skin biopsy is diagnostic for congenital ectodermal disorders or acquired inflammatory conditions
• Look for periadnexal lymphocytic infiltrates (supports AIGA diagnosis) 5

Exogenous causes:

• Review medications causing anticholinergic effects
• Assess for localized skin/sweat gland damage 7

Critical Clinical Considerations

Immediate Risk Assessment

Anhidrosis poses life-threatening heat intolerance risk—patients cannot dissipate heat through evaporative mechanisms, leading to hyperthermia, heat exhaustion, heat stroke, and death 7, 8. This is particularly critical for:

• Military personnel in heat-intensive environments 5
• Athletes and physically active individuals 3
• Patients in hot climates

Common Pitfalls to Avoid

1. Don't rely on SSR alone—it has poor sensitivity (31-76%) and age-related false positives 1
2. Don't perform TST as first-line test—it cannot distinguish postganglionic lesions and is resource-intensive 1
3. Don't delay treatment in suspected AIGA—early corticosteroid therapy yields better outcomes 5
4. Don't overlook associated conditions—30-60% of AIGA patients have cholinergic urticaria 3

Quality of Life Impact

Sudomotor dysfunction significantly impairs quality of life through:

• Dry skin and itching
• Heat intolerance limiting daily activities
• Increased foot ulceration risk (particularly in diabetes) 1
• Emotional distress from chronic symptoms 4

Address these systematically: counsel on heat avoidance, ensure adequate hydration, provide skin care for xerosis, and consider psychological support for chronic disease burden.